课题基金 / 基金详情

项目摘要

项目成果

MAXWELL J MEHLMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Two major forces in clinical medicine on the horizon are expected to change the paradigm of clinical care. One is personalized genomic medicine (PGM), which seeks to harness knowledge about the genetic endowment of the individual to individually tailor specific medical therapies. The second driving force in healthcare today is to conduct comparative effectiveness research (CER) to directly compare the effectiveness, and sometimes the cost, of alternative therapies or diagnostic modalities for the same disease or condition. As CER is conducted on alternative approaches to PGM, it is important for it to appropriately address the ethical, legal, and social concerns raised by genomic research, which have been elucidated by the ELSI program. To date, however, there has been no significant attempt to determine how the design and conduct of CER research on PGM should be shaped by the lessons from the ELSI program. This project aims to respond to this gap by comprehensively examining the specific ethical, legal, and social issues raised by comparative effectiveness research on personalized genomic medicine (CER/PGM), and to propose a set of points to consider in designing and conducting this research so that it can be carried out in an ethical, legal, and socially appropriate manner. PUBLIC HEALTH RELEVANCE: Both personalized genomic medicine and comparative effectiveness research are becoming increasingly important tools for improving the quality of health care and controlling health care costs, and the number of studies comparing the effectiveness of various personalized genomic interventions and approaches is expected to grow. While there has been a considerable effort to understand and address the ethical, legal, and social implications of personalized genomic medicine, there has been little attempt to apply this knowledge to the design, conduct, and translation of comparative effectiveness research on personalized genomic medicine. This project will identify these concerns and suggest how they can be appropriately addressed by this type of research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ethical, Legal, Social and Governance Issues in Non-Traditional Genetics and Genomics
  • 批准号:
    9921450
  • 项目类别:
  • 资助金额:
    $8.03万
  • 财政年份:
    2019
  • 负责人:
    MAXWELL J MEHLMAN
  • 依托单位:
Ethical, Legal, and Social Implications in Military Genomics
  • 批准号:
    8282359
  • 项目类别:
  • 资助金额:
    $7.85万
  • 财政年份:
    2012
  • 负责人:
    MAXWELL J MEHLMAN
  • 依托单位:
Ethical, Legal, and Social Implications in Military Genomics
  • 批准号:
    8458946
  • 项目类别:
  • 资助金额:
    $3.93万
  • 财政年份:
    2012
  • 负责人:
    MAXWELL J MEHLMAN
  • 依托单位:
Ethical Legal and Social Implications Issues in Comparative Effectiveness Researc
  • 批准号:
    8328948
  • 项目类别:
  • 资助金额:
    $35.33万
  • 财政年份:
    2011
  • 负责人:
    MAXWELL J MEHLMAN
  • 依托单位:
海外基金